Recommendations on Management of Latent Tuberculosis Infection in Patients Initiating Anti-tumor Necrosis Factor Biologics
Patients with immune-mediated inflammatory diseases on anti-tumor necrosis factor (TNF) agents are at increased risk of developing active tuberculosis (TB). Screening and treatment of latent tuberculosis infection (LTBI) with the use of a standard screening protocol is important in reducing the risk...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
World Scientific Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/37eec3f6dd3849a5b7eb305374b7845c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:37eec3f6dd3849a5b7eb305374b7845c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:37eec3f6dd3849a5b7eb305374b7845c2021-11-23T13:04:48ZRecommendations on Management of Latent Tuberculosis Infection in Patients Initiating Anti-tumor Necrosis Factor Biologics2661-34172661-342510.1142/S2661341721500012https://doaj.org/article/37eec3f6dd3849a5b7eb305374b7845c2021-12-01T00:00:00Zhttp://www.worldscientific.com/doi/epdf/10.1142/S2661341721500012https://doaj.org/toc/2661-3417https://doaj.org/toc/2661-3425Patients with immune-mediated inflammatory diseases on anti-tumor necrosis factor (TNF) agents are at increased risk of developing active tuberculosis (TB). Screening and treatment of latent tuberculosis infection (LTBI) with the use of a standard screening protocol is important in reducing the risk of TB reactivation during therapies with anti-TNF agents. The Latent Tuberculosis Infection Working Group under the Tuberculosis Control Coordinating Committee of the Department of Health and the Hospital Authority has reviewed and assessed local and international scientific evidence and formulated guideline statements on the management of LTBI in patients initiating anti-TNF biologics.Cecilia Kit Ying O’YoungKing Man HoHo SoThomas Yun Wing MokChi Chiu LeungChi Hung ChauChi Kuen ChanWorld Scientific Publishingarticleanti-tumor necrosis factor agentsactive tuberculosislatent tuberculosis infectionImmunologic diseases. AllergyRC581-607ENJournal of Clinical Rheumatology and Immunology, Vol 21, Iss 2, Pp 51-57 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
anti-tumor necrosis factor agents active tuberculosis latent tuberculosis infection Immunologic diseases. Allergy RC581-607 |
| spellingShingle |
anti-tumor necrosis factor agents active tuberculosis latent tuberculosis infection Immunologic diseases. Allergy RC581-607 Cecilia Kit Ying O’Young King Man Ho Ho So Thomas Yun Wing Mok Chi Chiu Leung Chi Hung Chau Chi Kuen Chan Recommendations on Management of Latent Tuberculosis Infection in Patients Initiating Anti-tumor Necrosis Factor Biologics |
| description |
Patients with immune-mediated inflammatory diseases on anti-tumor necrosis factor (TNF) agents are at increased risk of developing active tuberculosis (TB). Screening and treatment of latent tuberculosis infection (LTBI) with the use of a standard screening protocol is important in reducing the risk of TB reactivation during therapies with anti-TNF agents. The Latent Tuberculosis Infection Working Group under the Tuberculosis Control Coordinating Committee of the Department of Health and the Hospital Authority has reviewed and assessed local and international scientific evidence and formulated guideline statements on the management of LTBI in patients initiating anti-TNF biologics. |
| format |
article |
| author |
Cecilia Kit Ying O’Young King Man Ho Ho So Thomas Yun Wing Mok Chi Chiu Leung Chi Hung Chau Chi Kuen Chan |
| author_facet |
Cecilia Kit Ying O’Young King Man Ho Ho So Thomas Yun Wing Mok Chi Chiu Leung Chi Hung Chau Chi Kuen Chan |
| author_sort |
Cecilia Kit Ying O’Young |
| title |
Recommendations on Management of Latent Tuberculosis Infection in Patients Initiating Anti-tumor Necrosis Factor Biologics |
| title_short |
Recommendations on Management of Latent Tuberculosis Infection in Patients Initiating Anti-tumor Necrosis Factor Biologics |
| title_full |
Recommendations on Management of Latent Tuberculosis Infection in Patients Initiating Anti-tumor Necrosis Factor Biologics |
| title_fullStr |
Recommendations on Management of Latent Tuberculosis Infection in Patients Initiating Anti-tumor Necrosis Factor Biologics |
| title_full_unstemmed |
Recommendations on Management of Latent Tuberculosis Infection in Patients Initiating Anti-tumor Necrosis Factor Biologics |
| title_sort |
recommendations on management of latent tuberculosis infection in patients initiating anti-tumor necrosis factor biologics |
| publisher |
World Scientific Publishing |
| publishDate |
2021 |
| url |
https://doaj.org/article/37eec3f6dd3849a5b7eb305374b7845c |
| work_keys_str_mv |
AT ceciliakityingoyoung recommendationsonmanagementoflatenttuberculosisinfectioninpatientsinitiatingantitumornecrosisfactorbiologics AT kingmanho recommendationsonmanagementoflatenttuberculosisinfectioninpatientsinitiatingantitumornecrosisfactorbiologics AT hoso recommendationsonmanagementoflatenttuberculosisinfectioninpatientsinitiatingantitumornecrosisfactorbiologics AT thomasyunwingmok recommendationsonmanagementoflatenttuberculosisinfectioninpatientsinitiatingantitumornecrosisfactorbiologics AT chichiuleung recommendationsonmanagementoflatenttuberculosisinfectioninpatientsinitiatingantitumornecrosisfactorbiologics AT chihungchau recommendationsonmanagementoflatenttuberculosisinfectioninpatientsinitiatingantitumornecrosisfactorbiologics AT chikuenchan recommendationsonmanagementoflatenttuberculosisinfectioninpatientsinitiatingantitumornecrosisfactorbiologics AT recommendationsonmanagementoflatenttuberculosisinfectioninpatientsinitiatingantitumornecrosisfactorbiologics |
| _version_ |
1718416696268554240 |